Literature DB >> 31032328

Thyroid cancer staging and genomics.

Ashok R Shaha1, R Michael Tuttle2.   

Abstract

Entities:  

Year:  2019        PMID： 31032328      PMCID： PMC6462588          DOI： 10.21037/atm.2019.03.11

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  6 in total

1.  The relationship between central lymph node metastasis and the distance from tumor to thyroid capsule in papillary thyroid microcarcinoma without capsule invasion.

Authors:  Mengting Zhu; Weihui Zheng; Yangfeng Xiang; Jialei Gu; Kejing Wang; Jinbiao Shang
Journal:  Gland Surg       Date:  2020-06

2.  Copy Number Alterations in Papillary Thyroid Carcinomas: Does Loss of SESN2 Have a Role in Age-related Different Prognoses?

Authors:  Deise Cibele N DE Almeida; Michel Platini Caldas DE Souza; Carolina Koury Nassar Amorim; Jersey Heitor DA Silva MauÉs; Fernanda DO E Santo Sagica; Caroline Aquino Moreira-Nunes; Edivaldo Herculano C DE Oliveira
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

3.  Prediction of level V metastases in papillary thyroid microcarcinoma: a single center analysis.

Authors:  Wenlong Wang; Ning Bai; Qianhui Ouyang; Botao Sun; Chong Shen; Xinying Li
Journal:  Gland Surg       Date:  2020-08

4.  Evaluation of the diagnostic performance of contrast-enhanced ultrasound combined with BRAF V600E gene detection in nodules of unclear significance by thyroid fine-needle aspiration.

Authors:  Xi Zhu; Xuyang Peng; Lei Zhu; Lidan Xie; Feng Cheng; Bin Zhou
Journal:  Gland Surg       Date:  2021-01

5.  Correlation between thyroid autoantibodies and the risk of thyroid papillary carcinoma.

Authors:  Xuyang Peng; Xi Zhu; Feng Cheng; Bin Zhou; Xiaohua Zhu; Lei Zhu
Journal:  Gland Surg       Date:  2020-08

6.  Identification of key candidate genes and pathways in follicular variant papillary thyroid carcinoma by integrated bioinformatical analysis.

Authors:  Lanyu Jing; Fada Xia; Xin Du; Bo Jiang; Yong Chen; Xinying Li
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.